Anabolic Research
Anabolic research peptides drive protein synthesis through the IGF-1R or GH-axis pathways. IGF-1 LR3 directly engages the IGF-1 receptor with extended half-life vs native IGF-1. GH-axis peptides (ipamorelin, CJC-1295, tesamorelin) drive endogenous GH pulses that elevate hepatic IGF-1 production. All anabolic-axis compounds are prohibited at all times under WADA Section S2.
